These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 25254959)
21. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model. Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270 [TBL] [Abstract][Full Text] [Related]
22. Guava leaf extract attenuated muscle proteolysis in dexamethasone induced muscle atrophic mice via ubiquitin proteasome system, mTOR-autophagy, and apoptosis pathway. Lee H; Eo Y; Kim SY; Lim Y Nutr Res; 2024 Jul; 127():97-107. PubMed ID: 38909568 [TBL] [Abstract][Full Text] [Related]
24. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice. Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949 [TBL] [Abstract][Full Text] [Related]
26. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Milan G; Romanello V; Pescatore F; Armani A; Paik JH; Frasson L; Seydel A; Zhao J; Abraham R; Goldberg AL; Blaauw B; DePinho RA; Sandri M Nat Commun; 2015 Apr; 6():6670. PubMed ID: 25858807 [TBL] [Abstract][Full Text] [Related]
27. Curcumin Targeting NF- Zhang J; Zheng J; Chen H; Li X; Ye C; Zhang F; Zhang Z; Yao Q; Guo Y Mediators Inflamm; 2022; 2022():2567150. PubMed ID: 35132306 [TBL] [Abstract][Full Text] [Related]
28. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations. Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354 [TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways. Hiensch AE; Bolam KA; Mijwel S; Jeneson JAL; Huitema ADR; Kranenburg O; van der Wall E; Rundqvist H; Wengstrom Y; May AM Acta Physiol (Oxf); 2020 Jun; 229(2):e13400. PubMed ID: 31600860 [TBL] [Abstract][Full Text] [Related]
31. Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation. Schakman O; Dehoux M; Bouchuari S; Delaere S; Lause P; Decroly N; Shoelson SE; Thissen JP Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E729-39. PubMed ID: 22739109 [TBL] [Abstract][Full Text] [Related]
32. Dosing schedule-dependent attenuation of dexamethasone-induced muscle atrophy in mice. Nakao R; Yamamoto S; Yasumoto Y; Oishi K Chronobiol Int; 2014 May; 31(4):506-14. PubMed ID: 24397304 [TBL] [Abstract][Full Text] [Related]
33. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Barreto R; Waning DL; Gao H; Liu Y; Zimmers TA; Bonetto A Oncotarget; 2016 Jul; 7(28):43442-43460. PubMed ID: 27259276 [TBL] [Abstract][Full Text] [Related]
34. Cellular and molecular mechanisms of muscle atrophy. Bonaldo P; Sandri M Dis Model Mech; 2013 Jan; 6(1):25-39. PubMed ID: 23268536 [TBL] [Abstract][Full Text] [Related]
35. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle. Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784 [TBL] [Abstract][Full Text] [Related]
36. Dynamics and Interplay between Autophagy and Ubiquitin-proteasome system Coordination in Skeletal Muscle Atrophy. Singh A; Yadav A; Phogat J; Dabur R Curr Mol Pharmacol; 2022; 15(3):475-486. PubMed ID: 34365963 [TBL] [Abstract][Full Text] [Related]
37. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. Pin F; Barreto R; Couch ME; Bonetto A; O'Connell TM J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):140-154. PubMed ID: 30680954 [TBL] [Abstract][Full Text] [Related]
38. Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents. Ringseis R; Keller J; Lukas I; Spielmann J; Most E; Couturier A; König B; Hirche F; Stangl GI; Wen G; Eder K Biochim Biophys Acta; 2013 Jan; 1830(1):2105-17. PubMed ID: 23041501 [TBL] [Abstract][Full Text] [Related]
39. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
40. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions. Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]